EpistrySign in
LimitedMetadata only — full assessment not yet run

The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro

Leon Caly, Julian Druce, Mike Catton, David A. Jans, Kylie M. Wagstaff · Antiviral Research · 2020

DOI 10.1016/j.antiviral.2020.104787

Why this label

  • Metadata only — full assessment not yet run.

The Paper Scorecard

  • Standingclear
    • No retraction on record (OpenAlex metadata as of 2026-08-23).
  • Designjournal article
    • Journal article (Antiviral Research). Study design detail comes from the methodology read, not metadata.
  • Executionnot assessed
    • Metadata only — full assessment not yet run.
  • Corroborationhighly cited
    • Cited by 2276 works (OpenAlex citation count).
  • Provenanceidentified
    • Published in Antiviral Research.
    • Publisher: Elsevier BV.
    • ISSN 0166-3542.
    • The journal is not listed in DOAJ.
    • Open-access status: hybrid.
Assessed by Epistry · metadata as of August 23, 2026
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV… — Epistry